PDUFA Public Forum Previews Hill Debate; Safety, Critical Path Emphasized

With the Prescription Drug User Fee Act moving towards reauthorization, a public forum on Feb. 16 hinted at how that debate may play out on Capitol Hill. At the meeting sponsored by FDA, outside groups voiced concerns about the agency's proposal for the PDUFA program and made their case for how FDA should organize and spend requested funding

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet